Enhancing cranial defect repair in rats: investigating the effect of combining Total Flavonoids from Rhizoma Drynariae with calcium phosphate/collagen scaffolds.
Adjunctive therapy
Bone defect
Chinese medicine
Rhizoma Drynariae
Journal
Journal of orthopaedic surgery and research
ISSN: 1749-799X
Titre abrégé: J Orthop Surg Res
Pays: England
ID NLM: 101265112
Informations de publication
Date de publication:
28 Nov 2023
28 Nov 2023
Historique:
received:
14
10
2023
accepted:
20
11
2023
medline:
30
11
2023
pubmed:
29
11
2023
entrez:
29
11
2023
Statut:
epublish
Résumé
To investigate the therapeutic efficacy of total flavonoids of Rhizoma Drynariae (TFRD) in conjunction with a calcium phosphate/collagen scaffold for the repair of cranial defects in rats. The subjects, rats, were segregated into four groups: Control, TFRD, Scaffold, and TFRD + Scaffold. Cranial critical bone defects, 5 mm in diameter, were artificially induced through precise drilling. Post-surgery, at intervals of 2, 4, and 8 weeks, micro-CT scans were conducted to evaluate the progress of skull repair. Hematoxylin-eosin and Masson staining techniques were applied to discern morphological disparities, and immunohistochemical staining was utilized to ascertain the expression levels of local osteogenic active factors, such as bone morphogenetic protein 2 (BMP-2) and osteocalcin (OCN). Upon examination at the 8-week mark, cranial defects in the Scaffold and TFRD + Scaffold cohorts manifested significant repair, with the latter group displaying only negligible foramina. Micro-CT examination unveiled relative to its counterparts, and the TFRD + Scaffold groups exhibited marked bone regeneration at the 4- and 8-week intervals. Notably, the TFRD + Scaffold group exhibited substantial bone defect repair compared to the TFRD and Scaffold groups throughout the entire observation period, while histomorphological assessment demonstrated a significantly higher collagen fiber content than the other groups after 2 weeks. Immunohistochemical analysis further substantiated that the TFRD + Scaffold had augmented expression of BMP-2 at 2, 4 weeks and OCN at 2 weeks relative to other groups. The synergistic application of TFRD and calcium phosphate/collagen scaffold has been shown to enhance bone mineralization, bone plasticity, and bone histomorphology especially during initial osteogenesis phases.
Identifiants
pubmed: 38017558
doi: 10.1186/s13018-023-04398-w
pii: 10.1186/s13018-023-04398-w
pmc: PMC10683164
doi:
Substances chimiques
Flavonoids
0
Collagen
9007-34-5
Osteocalcin
104982-03-8
Calcium Phosphates
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
903Subventions
Organisme : Zhejiang Province Traditional Chinese Medicine Science and Technology Plan Project
ID : 2022ZB330
Organisme : National Natural Science Foundation of China
ID : No. 81970978
Informations de copyright
© 2023. The Author(s).
Références
Arch Plast Surg. 2023 Feb 06;50(1):82-95
pubmed: 36755653
J Am Acad Orthop Surg. 2005 Jan-Feb;13(1):77-86
pubmed: 15712985
J Appl Biomater Funct Mater. 2019 Oct-Dec;17(4):2280800019872594
pubmed: 31718388
Bone Res. 2015 Jan 20;3:14048
pubmed: 26273532
Clin Oral Investig. 2020 Jan;24(1):437-446
pubmed: 31104110
Endocrinology. 2005 Nov;146(11):4887-97
pubmed: 16099859
Emerg Med Int. 2022 Oct 29;2022:1022078
pubmed: 37008288
Biomed Pharmacother. 2022 Sep;153:113379
pubmed: 36076521
Adv Drug Deliv Rev. 2015 Apr;84:68-84
pubmed: 25453269
Zhongguo Zhong Yao Za Zhi. 2018 Jan;43(1):21-30
pubmed: 29552807
Chin Med. 2022 Jul 20;17(1):86
pubmed: 35858928
Maxillofac Plast Reconstr Surg. 2016 Jul 5;38(1):26
pubmed: 27441185
Stem Cells Int. 2019 Jul 1;2019:1351860
pubmed: 31354836
Nat Rev Immunol. 2019 Oct;19(10):626-642
pubmed: 31186549
Front Pharmacol. 2021 May 26;12:675470
pubmed: 34122101
Biomaterials. 2009 May;30(13):2479-88
pubmed: 19162318
Zhong Yao Cai. 2013 Aug;36(8):1287-92
pubmed: 24558828
Molecules. 2017 Jun 22;22(7):
pubmed: 28640230
J Ethnopharmacol. 2014 Dec 2;158 Pt A:94-101
pubmed: 25456426
Int J Implant Dent. 2021 May 24;7(1):40
pubmed: 34027572
Front Pharmacol. 2021 May 31;12:603734
pubmed: 34149403
J Orthop Surg Res. 2021 Dec 4;16(1):702
pubmed: 34863225
J Tissue Eng. 2010 Dec 13;2010:390127
pubmed: 21350644
Polymers (Basel). 2021 Sep 12;13(18):
pubmed: 34577976
Adv Sci (Weinh). 2020 Aug 07;7(19):2001334
pubmed: 33042751
Zhonghua Yi Xue Za Zhi. 2012 Aug 28;92(32):2288-91
pubmed: 23158493
BMC Musculoskelet Disord. 2022 Feb 17;23(1):157
pubmed: 35177068
Bone Rep. 2016 Sep 10;5:262-273
pubmed: 28580395
Phytother Res. 2022 Sep;36(9):3584-3600
pubmed: 35960140
Curr Comput Aided Drug Des. 2023;19(1):13-23
pubmed: 36201277
Sci Rep. 2020 Mar 4;10(1):4013
pubmed: 32132636
Arch Oral Biol. 2011 Dec;56(12):1655-62
pubmed: 21764032
Biomed Pharmacother. 2021 Jun;138:111480
pubmed: 33774316
Med Sci Monit. 2019 Aug 01;25:5700-5716
pubmed: 31368456